Mackenzie Maximum Diversification All World Developed ex North (TSX: MXU)
Canada
· Delayed Price · Currency is CAD
22.26
-0.06 (-0.27%)
Jun 28, 2024, 3:59 PM EDT
7.85% (1Y)
Assets | 22.20M |
Expense Ratio | 0.76% |
PE Ratio | 16.65 |
Dividend (ttm) | 0.61 |
Dividend Yield | 2.73% |
Ex-Dividend Date | Jun 24, 2024 |
Payout Frequency | Quarterly |
Payout Ratio | 45.49% |
1-Year Return | +7.38% |
Volume | 3,700 |
Open | 22.26 |
Previous Close | 22.32 |
Day's Range | n/a |
52-Week Low | 19.79 |
52-Week High | 23.03 |
Beta | 0.83 |
Holdings | 554 |
Inception Date | Sep 7, 2016 |
About MXU
Mackenzie Maximum Diversification All World Developed ex North (MXU) is an exchange-traded fund that trades on the Toronto Stock Exchange in Canada. It tracks an index of developed-country equity securities, excluding the US and Canada, filtered through a proprietary ESG criteria, and optimized to maximize a measure of diversification.
Asset Class Equity
Category Total Market
Stock Exchange Toronto Stock Exchange
Ticker Symbol MXU
Provider Mackenzie
Index Tracked TOBAM Maximum Diversification All World Developed ex Northe America Index - USD
Performance
MXU had a total return of 7.38% in the past year. Since the fund's inception, the average annual return has been 1.22%, including dividends.
Top 10 Holdings
14.86% of assetsName | Symbol | Weight |
---|---|---|
argenx SE | ARGX.BR | 1.78% |
UCB SA | UCB.BR | 1.59% |
Novartis AG Registered Shares | NOVN.SW | 1.52% |
Novo Nordisk A/S Class B | NOVO B.CO | 1.52% |
Sanofi SA | SAN.PA | 1.49% |
Teva Pharmaceutical Industries Ltd | TEVA.TA | 1.47% |
AstraZeneca PLC | AZN.L | 1.46% |
Nestle SA | NESN.SW | 1.37% |
Daiichi Sankyo Co Ltd | 4568.T | 1.33% |
Roche Holding AG | ROG.SW | 1.32% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Jun 24, 2024 | 0.20593 CAD | Jul 2, 2024 |
Mar 18, 2024 | 0.04555 CAD | Mar 26, 2024 |
Dec 18, 2023 | 0.21256 CAD | Dec 28, 2023 |
Sep 18, 2023 | 0.14415 CAD | Sep 26, 2023 |
Jun 19, 2023 | 0.21852 CAD | Jun 27, 2023 |
Mar 20, 2023 | 0.00729 CAD | Mar 28, 2023 |